# Structural-Bioinformatics-Modeling-Portfolio
dvanced portfolio showcasing 19 projects in Structure-Based Drug Design (SBDD), Homology Modeling (SWISS-MODEL), Protein-Ligand Docking, and Systems Biology (KEGG, STRING).
## ðŸ‘¨â€ðŸ”¬ Structural Bioinformatics & Molecular Modeling Portfolio

> This repository serves as a **unified professional portfolio** consolidating **19 distinct projects** that demonstrate advanced skills in Structural Biology, Molecular Modeling, and Systems Analysis. The collection showcases my ability to apply computational techniques to complex protein function, drug design, and translational data interpretation.

---

### âœ… Core Competencies & Technical Proficiency

| Competency Area | Description Emphasizing Human Effort | Primary Tools & Techniques Used |
| :--- | :--- | :--- |
| **I. Structural Biology & Modeling** | **I personally executed** detailed workflows for Homology Modeling (using SWISS-MODEL), analyzed PDB structures, and applied principles of molecular dynamics and refinement. | **SWISS-MODEL**, PDB Analysis, **Homology Modeling**, Protein Structure Refinement. |
| **II. Computational Drug Design (CADD)** | **I focused on applying** **Structure-Based Drug Design (SBDD)** principles through protein-ligand docking against relevant targets, including SARS-CoV-2 and inflammation markers. | **Molecular Docking**, Ligand-Protein Interaction Analysis, Target Validation. |
| **III. Systems & Evolutionary Analysis** | **I mastered the interpretation** of high-throughput data, mapping biological pathways (KEGG, Reactome), building PPI networks, and performing robust evolutionary (phylogenetic) inference. | **KEGG, REACTOME**, **STRING Database**, CLUSTAL OMEGA, MUSCLE (EMBL-EBI). |

---

### ðŸ“‚ Detailed Project Log: 19 Repositories

#### Category I: Systems Biology, Databases & Multi-Omic Analysis (4 Projects)

This section highlights high-level biological data interpretation, demonstrating the ability to work with complex systems and functional context.

| Order | Repository | Project Goal and Key Learning Outcome | Link |
| :---: | :--- | :--- | :--- |
| **1** | **Large-scale-Multi-omic-Analysis-of-COVID-19-Severity** | **Goal:** Integrate and analyze diverse genomic and proteomic data sets related to COVID-19 severity. **Outcome:** Gained experience in data fusion and translational bioinformatics. | [Link 18](https://github.com/DrNagendra619/Large-scale-Multi-omic-Analysis-of-COVID-19-Severity) |
| **2** | **String-database-Protein-Protein-Interactions-Network** | **Goal:** Map functional relationships between proteins. **Outcome:** Successfully constructed and interpreted a **Protein-Protein Interaction (PPI) Network** using the STRING database. | [Link 19](https://github.com/DrNagendra619/String-database-Protein-Protein-Interactions-Network) |
| **3** | **KEGG-DATABASE-PATHWAYS** | **Goal:** Map biological molecules to known metabolic and signaling routes. **Outcome:** Performed pathway enrichment analysis using the **KEGG Database**. | [Link 6](https://github.com/DrNagendra619/KEGG-DATABASE-PATHWAYS) |
| **4** | **REACTOME-DATABASE-PATHYWAYS** | **Goal:** Analyze molecular events in greater mechanistic detail. **Outcome:** Performed pathway analysis using the **REACTOME Database** for reaction-level context. | [Link 5](https://github.com/DrNagendra619/REACTOME-DATABASE-PATHYWAYS) |

#### Category II: Evolutionary & Sequence Modeling (4 Projects)

This category establishes proficiency in sequence comparison and phylogenetic methods using industry-standard tools. 

| Order | Repository | Project Goal and Key Learning Outcome | Core Methodology / Target Focus | Link |
| :---: | :--- | :--- | :--- |
| **5** | **PHYLOGENETIC-TREE-of-INSULIN-MUSCLE-TOOL** | **Goal:** Infer the evolutionary history of Insulin sequences. **Outcome:** Successfully used the **EMBL-EBI MUSCLE** tool for multiple sequence alignment and phylogenetic tree construction. | Insulin sequences, MUSCLE Tool. | [Link 1](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-INSULIN-USING-EMBL-EBI-MUSCLE-TOOL) |
| **6** | **PHYLOGENETIC-TREE-of-INSULIN-CLUSTAL-OMEGA-TOOL** | **Goal:** Validate evolutionary inference using a different algorithm. **Outcome:** Used the **EMBL-EBI CLUSTAL OMEGA** tool for comparative phylogenetic analysis of Insulin. | Insulin sequences, CLUSTAL OMEGA Tool. | [Link 2](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-INSULIN-CLUSTAL-OMEGA-TOOL) |
| **7** | **PHYLOGENETIC-TREE-of-Hemoglobin-MUSLCE-TOOL** | **Goal:** Infer the evolutionary history of Hemoglobin sequences. **Outcome:** Applied the **MUSCLE** tool for alignment and tree generation. | Hemoglobin sequences, MUSCLE Tool. | [Link 3](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-Hemoglobin-EMBL-EBI-MUSLCE-TOOL) |
| **8** | **PHYLOGENETIC-TREE-of-Hemoglobin-CLUSTAL-OMEGA-TOOL** | **Goal:** Validate evolutionary inference for Hemoglobin. **Outcome:** Applied the **CLUSTAL OMEGA** tool for alignment and tree generation. | Hemoglobin sequences, CLUSTAL OMEGA Tool. | [Link 4](https://github.com/DrNagendra619/CONSTRUCTING-A-PHYLOGENETIC-TREE-of-Hemoglobin-EMBL-EBI-CLUSTAL-OMEGA-TOOL) |

#### Category III: Structural Biology, Homology Modeling & Drug Design (11 Projects)

This is the most specialized section, showing a progression from basic structure analysis to building new models and applying them in drug design. 

| Order | Repository | Project Goal and Key Learning Outcome | Core Methodology / Target Focus | Link |
| :---: | :--- | :--- | :--- |
| **9** | **Protein-2-Structure-analysis-1AO3...** | **Goal:** Analyze an existing PDB file for functional regions. **Outcome:** Performed structural analysis and interpretation of the **Von Willebrand Factor** A3 Domain (1AO3). | Structural Analysis (PDB). | [Link 12](https://github.com/DrNagendra619/Protein-2-Structure-analysis-1AO3-A3-DOMAIN-OF-VON-WILLEBRAND-FACTOR-) |
| **10** | **Protein-2-Structure-analysis-1KTH...** | **Goal:** Analyze high-resolution PDB data. **Outcome:** Interpreted structural features from the **Kunitz-Type Domain C5** at high resolution (1KTH). | Structural Analysis (PDB Refinement). | [Link 13](https://github.com/DrNagendra619/Protein-2-Structure-analysis-1KTH-Anisotropic-Refinement-Of-Kunitz-Type-Domain-C5-at-0.95-Angstrom) |
| **11** | **Protein-2-Structure-analysis-6KA9...** | **Goal:** Analyze structural modifications in proteins. **Outcome:** Interpreted PDB data for **Crosslinked Human Hemoglobin** (6KA9). | Structural Analysis (PDB). | [Link 14](https://github.com/DrNagendra619/Protein-2-Structure-analysis-6KA9-Crosslinked-alpha-Fe-CO--beta-Ni-human-hemoglobin-A) |
| **12** | **PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING--2DN1...** | **Goal:** Predict 3D structure from a sequence (Homology Modeling). **Outcome:** Successfully modeled **Human Hemoglobin** using **SWISS-MODEL**. | Homology Modeling. | [Link 7](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING--2DN1-Human-Hemoglobin) |
| **13** | **PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-2QAC...** | **Goal:** Model a complex protein structure. **Outcome:** Successfully modeled the **MTIP-MyosinA-tail complex** (2QAC) using SWISS-MODEL. | Homology Modeling. | [Link 8](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-2QAC-closed-MTIP-MyosinA-tail-complex) |
| **14** | **PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-7LYH...** | **Goal:** Model a contemporary viral target. **Outcome:** Successfully modeled a **SARS-CoV-2 protein** (7LYH) using SWISS-MODEL. | Homology Modeling. | [Link 9](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-MODELLING-SWISS-MODELLING-7LYH-Crystal-structure-of-the-SARS-CoV-2) |
| **15** | **PROTEIN-STRUCTURE-SWISS-MODELLING--7BF4...** | **Goal:** Model a second viral target for comparison. **Outcome:** Successfully modeled a second **SARS-CoV-2 protein** (7BF4) using SWISS-MODEL. | Homology Modeling. | [Link 10](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-SWISS-MODELLING--7BF4-Crystal-structure-of-SARS-CoV-2) |
| **16** | **PROTEIN-STRUCTURE-SWISS-MODELLING-2ZNS...** | **Goal:** Model a neurological target. **Outcome:** Successfully modeled the structure of the human **glutamate receptor** (2ZNS) using SWISS-MODEL. | Homology Modeling. | [Link 11](https://github.com/DrNagendra619/PROTEIN-STRUCTURE-SWISS-MODELLING-2ZNS-Structure-of-ligand-binding-core-of-human-glutamate-receptor) |
| **17** | **PROTEIN-LIGAND-DOCKING-6Y3C-Human-COX-1...** | **Goal:** Simulate drug-target binding (SBDD). **Outcome:** Performed **Protein-Ligand Docking** against the **Human COX-1** enzyme (6Y3C). | Drug Design (SBDD). | [Link 15](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-6Y3C-Human-COX-1-Crystal-Structure-) |
| **18** | **PROTEIN-LIGAND-DOCKING-7L0D-SARS-CoV-2...** | **Goal:** Simulate binding for an urgent target. **Outcome:** Performed **Protein-Ligand Docking** against the **SARS-CoV-2 Main Protease (Mpro)** (7L0D). | Drug Design (SBDD). | [Link 16](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-7L0D-SARS-CoV-2-Main-Protease-Mpro-in-Complex-with-ML188-) |
| **19** | **PROTEIN-LIGAND-DOCKING-8IFR-SARS-CoV-2...** | **Goal:** Validate docking results against another key viral target. **Outcome:** Performed **Protein-Ligand Docking** against the **SARS-CoV-2 3CL Protease** (8IFR). | Drug Design (SBDD). | [Link 17](https://github.com/DrNagendra619/PROTEIN-LIGAND-DOCKING-8IFR-SARS-CoV-2-3CL-protease-3CLpro-in-complex-with-compound-3-) |

---

### ðŸŽ“ Personal Statement and Future Direction

> This portfolio rigorously documents my commitment to **Structure-Based Drug Design (SBDD)** and advanced computational analysis. By mastering techniques from homology modeling to molecular docking and systems mapping, I have established a specialized skill set ready for immediate application in **Pharmaceutical Research and Industrial Bioinformatics** roles.

---

The video provided below offers further context on why structural biology is central to modern drug discovery efforts.

[Penn Structural Biology: The Future of Drug Discovery](https://www.youtube.com/watch?v=r0xCFh_cHrI)


http://googleusercontent.com/youtube_content/0
